Audit shows that pharma companies are still cheating by suppressing trials

an article by Cory Doctorow for the Boing Boing blog


Image: ParentingPatch, CC-BY-SA

It’s been years since the major pharma companies agreed to participate in the Registry of All Trials, meaning that they’d end the practice of only reporting on trials whose outcomes they were pleased with, leaving about half of all trials unreported-on.

Today [which was 27 July 2017], Ben Goldacre (who is the Registry’s most prominent advocate) and colleagues released a paper in the British Medical Journal reporting on their audit of pharmaceutical companies' record on keeping that promise.

And so it goes on. 

Continue reading Cory’s post

Find more information on the Index

Read the BMJ article (in full)

---